Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 3/2021

01-07-2021 | Hypopigmentation | Images

Importance of Morphology in the Era of Molecular Biology: Lesson Learnt from a Case of Chediak–Higashi Syndrome

Authors: Ankita Singh, Ankur Kumar Jindal, Raviteja Indla, Praveen Sharma, Neelam Varma, Amit Rawat

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2021

Login to get access

Excerpt

A 4-years-old boy presented with recurrent episodes of fever since 6 months of age associated with bilateral neck swellings, scalp abscesses and intermittent bilateral ear discharge requiring recurrent hospital admissions. On examination, he had microcephaly, diffuse skin hypopigmentation (Fig. 1a), silver-grey hair, pallor, periodontitis (Fig. 1b), generalized lymphadenopathy and hepatosplenomegaly. Investigations revealed hemoglobin of 70 g/L, platelet count 88 × 109/L, and total leukocyte count 6.7 × 109/L with an absolute neutrophil count of 0.873 × 109/L. Peripheral blood examination revealed discrete to multiple irregular large round-to-oval purple colored peroxidase positive intra-cytoplasmic inclusions (~ 1–2µ in diameter) in the neutrophils, lymphocytes and monocytes (Fig. 1c, d). Considering above findings, a diagnosis of Chédiak–Higashi syndrome (CHS) was considered. Hair-shaft microscopy revealed small regularly distributed clumps of melanin in the cortex (Fig. 1e). Bone marrow aspiration was done to identify the cause of cytopenia which showed similar granules in neutrophils and its precursors, monocytes and lymphocytes along with few haemophagocytic histiocytes (Fig. 1f). He was diagnosed as a case of CHS in accelerated phase and initiated on high-dose ascorbic acid (500 mg/day) with cotrimoxazole prophylaxis (60 mg/day). Genetic testing revealed mutation in LYST gene (c.10371delT), confirming the diagnosis of CHS.
Metadata
Title
Importance of Morphology in the Era of Molecular Biology: Lesson Learnt from a Case of Chediak–Higashi Syndrome
Authors
Ankita Singh
Ankur Kumar Jindal
Raviteja Indla
Praveen Sharma
Neelam Varma
Amit Rawat
Publication date
01-07-2021
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01395-5

Other articles of this Issue 3/2021

Indian Journal of Hematology and Blood Transfusion 3/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine